XML 39 R27.htm IDEA: XBRL DOCUMENT v3.26.1
Fair Value Measurements (Tables)
3 Months Ended
Mar. 31, 2026
Fair Value Disclosures [Abstract]  
Schedule of Recurring Measurements
The following table summarizes the financial instruments remeasured at fair value on a recurring basis:
Fair Value Measurements as of
March 31, 2026December 31, 2025
Cash Flow Hedges: (a) (b)
Level 1Level 2 (c)Level 3Level 1Level 2 (c)Level 3
Derivative interest rate swap assets— $6,041 — — $5,196 — 
Derivative interest rate swap liabilities$— $(48)$— $— $(435)$— 
(a)During the twelve months subsequent to March 31, 2026, an estimated $4,351 of derivative interest rate balances recognized in accumulated comprehensive income will be reclassified into earnings.
(b)As of March 31, 2026 and December 31, 2025, the Company determined that the credit valuation adjustments associated with nonperformance risk are not significant to the overall valuation of its derivatives. As a result, the Company's derivative valuations in their entirety are classified as Level 2 of the fair value hierarchy.
(c)Derivative assets or liabilities are recognized as a part of deferred costs and other assets, net or other liabilities, respectively.
Schedule of Financial Instruments Not Measured at Fair Value
The following table summarizes the estimated fair value of financial instruments presented at carrying values in the Company's condensed consolidated financial statements as of March 31, 2026 and December 31, 2025:
March 31, 2026December 31, 2025
Carrying ValueEstimated 
Fair Value
Market
Interest Rate
Carrying ValueEstimated 
Fair Value
Market
Interest Rate
Mortgages Payable$117,412 $112,294 6.05 %$117,605 $111,945 6.09 %
Senior Notes250,000 246,244 5.47 %250,000 248,320 5.24 %
Term Loan400,000 399,642 4.74 %400,000 398,701 4.64 %
Revolving Credit Facility181,000 181,086 4.57 %55,000 54,957 4.37 %